Similar Articles
1551 Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review
1552 Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
1553 Is human hepatocellular carcinoma a hormone-responsive tumor?
1554 Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma
1555 Activins and activin antagonists in hepatocellular carcinoma
1556 Current role of ultrasound for the management of hepatocellular carcinoma
1557 Tumor suppressor and hepatocellular carcinoma
1558 Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma
1559 DNA methylation in hepatocellular carcinoma
1560 High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA